BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 30904173)

  • 1. Neoadjuvant chemoradiation followed by transanal local excision for T2 rectal cancer confers equivalent survival benefit as traditional transabdominal resection.
    Jawitz OK; Adam MA; Turner MC; Gilmore BF; Migaly J
    Surgery; 2019 Jun; 165(6):1193-1198. PubMed ID: 30904173
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term outcome of local excision after preoperative chemoradiation for ypT0 rectal cancer.
    Stipa F; Picchio M; Burza A; Soricelli E; Vitelli CE
    Dis Colon Rectum; 2014 Nov; 57(11):1245-52. PubMed ID: 25285690
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transanal local excision for distal rectal cancer and incomplete response to neoadjuvant chemoradiation - does baseline staging matter?
    Perez RO; Habr-Gama A; São Julião GP; Proscurshim I; Coelho AQ; Figueiredo MN; Fernandez LM; Gama-Rodrigues J
    Dis Colon Rectum; 2014 Nov; 57(11):1253-9. PubMed ID: 25285691
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Completely Abdominal Approach Laparoscopic Partial Intersphincteric Resection After Neoadjuvant Chemoradiation for Initial cT3 Juxta-Anal Rectal Cancer.
    Huang S; Huang Y; Chi P; Lin H; Lu X; Xu Z; Sun Y; Wang X
    J Laparoendosc Adv Surg Tech A; 2019 Jun; 29(6):809-816. PubMed ID: 30596539
    [No Abstract]   [Full Text] [Related]  

  • 5. Organ preservation for clinical T2N0 distal rectal cancer using neoadjuvant chemoradiotherapy and local excision (ACOSOG Z6041): results of an open-label, single-arm, multi-institutional, phase 2 trial.
    Garcia-Aguilar J; Renfro LA; Chow OS; Shi Q; Carrero XW; Lynn PB; Thomas CR; Chan E; Cataldo PA; Marcet JE; Medich DS; Johnson CS; Oommen SC; Wolff BG; Pigazzi A; McNevin SM; Pons RK; Bleday R
    Lancet Oncol; 2015 Nov; 16(15):1537-1546. PubMed ID: 26474521
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transanal excision with adjuvant therapy for pT1N0 rectal tumors with high-risk features offers equivalent survival to radical resection: A National Cancer Database analysis.
    Hrebinko KA; Reitz KM; Mohammed MK; Nassour I; Watson AR; Cunningham KE; Medich DS; Celebrezze JP; Holder-Murray JM
    J Surg Oncol; 2022 Mar; 125(3):475-483. PubMed ID: 34705273
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemoradiation and Local Excision for T2N0 Rectal Cancer Offers Equivalent Overall Survival Compared to Standard Resection: a National Cancer Database Analysis.
    Lee L; Kelly J; Nassif GJ; Atallah SB; Albert MR; Shridhar R; Monson JRT
    J Gastrointest Surg; 2017 Oct; 21(10):1666-1674. PubMed ID: 28819913
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transanal endoscopic microsurgery for residual rectal cancer (ypT0-2) following neoadjuvant chemoradiation therapy: another word of caution.
    Perez RO; Habr-Gama A; Lynn PB; São Julião GP; Bianchi R; Proscurshim I; Gama-Rodrigues J
    Dis Colon Rectum; 2013 Jan; 56(1):6-13. PubMed ID: 23222274
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Survival Outcomes After Surgical Management of the Primary Tumor With and Without Radiotherapy for Metastatic Rectal Adenocarcinoma: A National Cancer Database (NCDB) Analysis.
    Renz P; Wegner RE; Hasan S; Brookover R; Finley G; Monga D; Raj M; McCormick J; Kirichenko A
    Clin Colorectal Cancer; 2019 Jun; 18(2):e237-e243. PubMed ID: 30905549
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A systematic review of local excision followed by adjuvant therapy in early rectal cancer: are pT1 tumours the limit?
    Cutting JE; Hallam SE; Thomas MG; Messenger DE
    Colorectal Dis; 2018 Oct; 20(10):854-863. PubMed ID: 29992729
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term Oncologic Outcomes After Neoadjuvant Chemoradiation Followed by Intersphincteric Resection With Coloanal Anastomosis for Locally Advanced Low Rectal Cancer.
    Park JS; Park SY; Kim HJ; Cho SH; Kwak SG; Choi GS
    Dis Colon Rectum; 2019 Apr; 62(4):408-416. PubMed ID: 30688680
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Individual participant data pooled-analysis of risk factors for recurrence after neoadjuvant radiotherapy and transanal local excision of rectal cancer: the PARTTLE study.
    Arezzo A; Lo Secco G; Passera R; Esposito L; Guerrieri M; Ortenzi M; Bujko K; Perez RO; Habr-Gama A; Stipa F; Picchio M; Restivo A; Zorcolo L; Coco C; Rizzo G; Mistrangelo M; Morino M
    Tech Coloproctol; 2019 Sep; 23(9):831-842. PubMed ID: 31388861
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does Delaying Surgical Resection After Neoadjuvant Chemoradiation Impact Clinical Outcomes in Locally Advanced Rectal Adenocarcinoma?: A Single-Institution Experience.
    Nguyen P; Wuthrick E; Chablani P; Robinson A; Simmons L; Wu C; Arnold M; Harzman AE; Husain S; Schmidt C; Abdel-Misih S; Bekaii-Saab T; Chakravarti A; Williams TM
    Am J Clin Oncol; 2018 Feb; 41(2):140-146. PubMed ID: 26535992
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of Transanal Total Mesorectal Excision With Local Recurrence of Rectal Cancer.
    Caycedo-Marulanda A; Lee L; Chadi SA; Verschoor CP; Crosina J; Ashamalla S; Brown CJ;
    JAMA Netw Open; 2021 Feb; 4(2):e2036330. PubMed ID: 33533932
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improved outcomes for rectal cancer in the era of preoperative chemoradiation and tailored mesorectal excision: a series of 338 consecutive cases.
    Pacelli F; Sanchez AM; Covino M; Tortorelli AP; Bossola M; Valentini V; Gambacorta MA; Doglietto GB
    Am Surg; 2013 Feb; 79(2):151-61. PubMed ID: 23336654
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic Value of Clinical vs Pathologic Stage in Rectal Cancer Patients Receiving Neoadjuvant Therapy.
    Delitto D; George TJ; Loftus TJ; Qiu P; Chang GJ; Allegra CJ; Hall WA; Hughes SJ; Tan SA; Shaw CM; Iqbal A
    J Natl Cancer Inst; 2018 May; 110(5):460-466. PubMed ID: 29165692
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Evaluation of progression-free survival for locally advanced rectal cancer by MRI after neoadjuvant chemoradiotherapy and total mesorectal excision].
    Zhang JX; Yang Z; Fan P; Zhang JJ; Xin L; Hou LN; Du XS; Yang XT
    Zhonghua Zhong Liu Za Zhi; 2018 Feb; 40(2):121-126. PubMed ID: 29502372
    [No Abstract]   [Full Text] [Related]  

  • 18. Comparative Effectiveness of Neoadjuvant Chemoradiation Versus Upfront Surgery in the Management of Recto-Sigmoid Junction Cancer.
    Venigalla S; Chowdhry AK; Wojcieszynski AP; Lukens JN; Plastaras JP; Metz JM; Ben-Josef E; Mahmoud NN; Reiss KA; Shabason JE
    Clin Colorectal Cancer; 2018 Sep; 17(3):e557-e568. PubMed ID: 29910004
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of transanal local excision of early rectal cancer on completion rectal resection without neoadjuvant chemoradiotherapy: a systematic review.
    Zinicola R; Nascimbeni R; Cirocchi R; Gagliardi G; Cracco N; Giuffrida M; Pedrazzi G; Binda GA
    Tech Coloproctol; 2021 Sep; 25(9):997-1010. PubMed ID: 34173121
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complementary use of local excision and transanal endoscopic microsurgery for rectal cancer after neoadjuvant chemoradiation.
    Caricato M; Borzomati D; Ausania F; Tonini G; Rabitti C; Valeri S; Trodella L; Ripetti V; Coppola R
    Surg Endosc; 2006 Aug; 20(8):1203-7. PubMed ID: 16703429
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.